Cargando…
Systematic construction and validation of an epithelial–mesenchymal transition risk model to predict prognosis of lung adenocarcinoma
Epithelial–mesenchymal transition (EMT) has been shown to be linked to a poor prognosis, particularly in patients with non-small-cell lung cancer. Nevertheless, little is known regarding the existence of EMT-related gene signatures and their prognostic values in lung adenocarcinoma (LUAD). In the cu...
Autores principales: | Tang, Yunliang, Jiang, Yanxia, Qing, Cheng, Wang, Jiao, Zeng, Zhenguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835007/ https://www.ncbi.nlm.nih.gov/pubmed/33340396 http://dx.doi.org/10.18632/aging.202186 |
Ejemplares similares
-
Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma
por: Wang, Jiao, et al.
Publicado: (2020) -
Gene expression and prognosis of sirtuin family members in ovarian cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020) -
Association between epithelial‐mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma
por: Sowa, Terumasa, et al.
Publicado: (2015) -
TCTP promotes epithelial–mesenchymal transition in lung adenocarcinoma
por: Sun, Ruilin, et al.
Publicado: (2019) -
ARNTL2 is an indicator of poor prognosis, promotes epithelial-to-mesenchymal transition and inhibits ferroptosis in lung adenocarcinoma
por: Zhang, Huan, et al.
Publicado: (2022)